Kilambi News
Friday, November 20, 2026

Archive

Every story, newest first.

Saturday, November 7, 2026

Life Sciences

Servier drug sevasemten fails Becker muscular dystrophy trial

Sevasemten, the muscular dystrophy drug Servier bought from Edgewise Therapeutics for 1.55 billion dollars upfront five months ago, missed its primary and secondary endpoints in the pivotal GRAND CANYON Phase 2 trial in Becker muscular dystrophy.

Life Sciences

Satellos switches Duchenne trial endpoint to MRI measure

Following FDA feedback, Satellos Bioscience has made change in MRI measured muscle fat fraction the primary efficacy endpoint of its Phase 2 BASECAMP trial of forazapadin in 53 boys with Duchenne muscular dystrophy.

Life Sciences

Sarepta closes enrollment in Elevidys confirmatory trial ENVISION

Sarepta Therapeutics will not resume enrollment in ENVISION, the Phase 3 confirmatory trial for its Duchenne gene therapy Elevidys, which enrolled 90 participants and has been on global hold for more than a year.

Life Sciences

Moderna swings to profit and raises revenue outlook

Moderna reported third quarter net income of 162 million dollars on revenue of 1.31 billion dollars, up 29 percent year on year, against a net loss of 200 million dollars a year earlier.

Life Sciences

Lilly puts Zepbound and Foundayo on Hims platform

Eli Lilly will sell its obesity medicines Zepbound and Foundayo directly through the Hims and Hers telehealth platform at self pay prices starting at 299 dollars and 149 dollars a month.

Mining

Mining also notable: copper slide and uranium consolidation

Copper slid to its lowest since July as TD Securities warned of further downside, Canadian Uranium set out an acquisition led Athabasca strategy around Rook II, and Jubilee's $35 million waste project sale moved through due diligence.

Mining

Imperial Metals third quarter profit falls to $1.2 million

Imperial Metals' net income fell to $1.2 million in the third quarter from $38.5 million a year earlier, as lower grades and recovery cut production at both Mount Polley and Red Chris.

Mining

IAMGOLD holds guidance and buys back Cote royalty

IAMGOLD produced 186,900 attributable ounces in the third quarter, held full year guidance at 720,000 to 820,000 ounces, and moved to repurchase half the Cote Gold royalty for about $525 million.

Mining

Ghana forgoes $6.56 billion mining revenue, IFS estimates

Ghana could have collected an additional $6.56 billion from mining in 2025 if it had matched Botswana's revenue capture rate, the Institute for Fiscal Studies estimates, against actual mining revenue of $1.60 billion on $13.40 billion of value added.

Mining

Contract worker dies at Regis Duketon South operation

A 75 year old contract worker died in a workplace incident at Regis Resources' Duketon South gold operation in Western Australia on November 6, and operations at Duketon have been suspended while police and WorkSafe investigate.